SDZ 224-015 is primarily investigated for its potential therapeutic applications in the field of medicine, particularly in oncology. It has shown promise as an anti-cancer agent due to its ability to inhibit specific cellular pathways that are crucial for tumor growth and survival. Researchers are exploring its efficacy in targeting various types of cancers, with a focus on its role in inducing apoptosis in cancer cells while sparing healthy tissues. Additionally, SDZ 224-015 is being studied for its potential to enhance the effectiveness of existing chemotherapy treatments, potentially reducing the required dosage of traditional chemotherapeutic drugs and minimizing side effects. Its application extends to preclinical studies, where it is being evaluated for its pharmacokinetics, safety profile, and overall therapeutic potential.